Improved overall survival with checkpoint inhibition and allogeneic transplantation in relapsed Hodgkin lymphoma
复发性霍奇金淋巴瘤患者采用免疫检查点抑制剂和异基因移植治疗后，总体生存率得到提高
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015048
Tabbara, Nadeem; Zahurak, Marianna; Sterling, Cole H; Trutzer, Iris Margalit; Jedrych, Jaroslaw; Swinnen, Lode J; Fuchs, Ephraim J; Bolaños-Meade, Javier; Wagner-Johnston, Nina; Jones, Richard J; Ambinder, Richard F; Varadhan, Ravi; Paul, Suman
